PL196505A1 - METHOD OF MAKING NEW AMINO-ALKYLETERCYCLIC COMPOUNDS - Google Patents

METHOD OF MAKING NEW AMINO-ALKYLETERCYCLIC COMPOUNDS

Info

Publication number
PL196505A1
PL196505A1 PL19650577A PL19650577A PL196505A1 PL 196505 A1 PL196505 A1 PL 196505A1 PL 19650577 A PL19650577 A PL 19650577A PL 19650577 A PL19650577 A PL 19650577A PL 196505 A1 PL196505 A1 PL 196505A1
Authority
PL
Poland
Prior art keywords
alkyletercyclic
compounds
new amino
making new
amino
Prior art date
Application number
PL19650577A
Other languages
Polish (pl)
Other versions
PL111240B1 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of PL196505A1 publication Critical patent/PL196505A1/en
Publication of PL111240B1 publication Critical patent/PL111240B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
PL1977196505A 1976-03-09 1977-03-08 Method of manufacturing novel aminoalkylheterocyclic compounds PL111240B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (en) 1976-03-09 1976-03-09 AMINOALKYLHETEROCYCLES

Publications (2)

Publication Number Publication Date
PL196505A1 true PL196505A1 (en) 1979-06-18
PL111240B1 PL111240B1 (en) 1980-08-30

Family

ID=5971857

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1977215210A PL112937B1 (en) 1976-03-09 1977-03-08 Method of manufacture of novel aminoalkylheterocyclic compounds
PL1977196505A PL111240B1 (en) 1976-03-09 1977-03-08 Method of manufacturing novel aminoalkylheterocyclic compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1977215210A PL112937B1 (en) 1976-03-09 1977-03-08 Method of manufacture of novel aminoalkylheterocyclic compounds

Country Status (36)

Country Link
US (4) US4154829A (en)
JP (2) JPS52108970A (en)
AT (1) AT360542B (en)
AU (1) AU515953B2 (en)
BE (1) BE852223A (en)
BG (4) BG27743A3 (en)
CA (1) CA1086317A (en)
CH (8) CH630358A5 (en)
CS (2) CS220320B2 (en)
DD (1) DD130037A5 (en)
DE (1) DE2609645A1 (en)
DK (1) DK102177A (en)
ES (10) ES456622A1 (en)
FI (1) FI69070C (en)
FR (2) FR2343731A1 (en)
GB (1) GB1571231A (en)
GR (1) GR64553B (en)
HK (1) HK12884A (en)
HU (1) HU177953B (en)
IE (1) IE45300B1 (en)
IL (1) IL51627A (en)
LU (1) LU76898A1 (en)
MX (1) MX4878E (en)
MY (1) MY8500079A (en)
NL (1) NL7702403A (en)
NO (1) NO147950C (en)
NZ (1) NZ183536A (en)
PH (3) PH16110A (en)
PL (2) PL112937B1 (en)
PT (1) PT66282B (en)
RO (3) RO79706A (en)
SE (1) SE435059B (en)
SG (1) SG55583G (en)
SU (4) SU698530A3 (en)
YU (1) YU62377A (en)
ZA (1) ZA771412B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES
DE2644833A1 (en) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE AMINOPROPANES AND METHOD FOR THE PRODUCTION THEREOF
DE2833140A1 (en) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim NEW N-SUBSTITUTED HETEROCYCLES
BE883069A (en) 1979-05-04 1980-08-18 Continental Pharma PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND USE AS WELL AS A COMPOSITION CONTAINING THESE DERIVATIVES.
DE3026534A1 (en) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-BENZOXAZINE-2-ONE, THEIR PRODUCTION AND USE
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (en) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim NEW 1-PHENYLIMIDAZOLIDIN-2-ON DERIVATIVES, THEIR PRODUCTION AND USE
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (en) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5808080A (en) 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (en) 1996-09-05 2002-09-16 Lilly Co Eli CARBAZOL ANALOGS AS BETA3 SELECTIVE ADRENERGIC AGONISTS.
CO5011072A1 (en) * 1997-12-05 2001-02-28 Lilly Co Eli ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS
DK1385515T3 (en) 2001-04-18 2008-10-27 Euro Celtique Sa Spiropyrazole compounds
SI1975164T1 (en) * 2001-04-18 2010-05-31 Euro Celtique Sa Octahydrobenzimidazolone compounds as analgetics
DE60231257D1 (en) * 2001-04-18 2009-04-02 Euro Celtique Sa 1- (4-PIPERIDINYL) -1,3-DIHYDRO-2H-INDOL-2-ON DERIVATIVES AND RELATED COMPOUNDS AS NOCICEPTIN ANALOGS AND ORL1 LIGANDS FOR THE TREATMENT OF PAIN
IL158486A0 (en) * 2001-04-18 2004-05-12 Euro Celtique Sa Nociceptin analogs
AU2002256282C1 (en) 2001-04-18 2006-08-17 Euroceltique S.A. Spiroindene and spiroindane compounds
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
JP2006509790A (en) * 2002-11-27 2006-03-23 アルテシアン セラピューティック，インコーポレイティド Compounds with mixed PDE inhibition and beta-adrenergic antagonist activity or partial agonist activity for the treatment of heart failure
WO2004058726A2 (en) * 2002-12-23 2004-07-15 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
DE102004001413A1 (en) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of chronic obstructive pulmonary disease
DE102004003428A1 (en) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (en) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004045648A1 (en) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg New betamimetics for the treatment of respiratory diseases
US20080090827A1 (en) * 2004-11-30 2008-04-17 Artesian Therapeutics, Inc. Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
EP1833480A2 (en) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102005007654A1 (en) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting betamimetics for the treatment of respiratory diseases
DE102005030733A1 (en) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
BRPI0614410A2 (en) * 2005-08-15 2011-03-29 Boehringer Ingelheim Int betamimetic preparation process
DE102005052102A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
DE102005052101A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
DE102005052127A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel indole beta-agonists, process for their preparation and their use as pharmaceuticals
EP1986644A1 (en) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Drug combinations for the treatment of respiratory tract diseases
PE20080142A1 (en) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int ENANTHOMERICALLY PURE BETA-AGONISTS AND THEIR PREPARATION PROCEDURES
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (en) * 1929-08-10 1931-08-15 Chem Ind Basel Process for the preparation of an N-substituted compound of the pyridone series.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (en) * 1961-10-24
FR1516714A (en) * 1962-11-07 1968-02-05 Bayer Ag Process for preparing imidazolidine derivatives
FR1384708A (en) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Improvements to devices for placing objects
BE659364A (en) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (en) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (en) * 1971-08-04 1973-02-02 Pfizer NEW PROPANOLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES

Also Published As

Publication number Publication date
ES456622A1 (en) 1978-03-16
IE45300L (en) 1977-09-09
PL112937B1 (en) 1980-11-29
LU76898A1 (en) 1978-06-01
YU62377A (en) 1982-10-31
IE45300B1 (en) 1982-07-28
CH630365A5 (en) 1982-06-15
FR2343731A1 (en) 1977-10-07
CH630360A5 (en) 1982-06-15
US4215119A (en) 1980-07-29
AU515953B2 (en) 1981-05-14
NZ183536A (en) 1981-11-19
SG55583G (en) 1984-07-27
PT66282A (en) 1977-04-01
RO76589A (en) 1981-04-30
CH630358A5 (en) 1982-06-15
US4363814A (en) 1982-12-14
SE7702609L (en) 1977-10-11
CH630359A5 (en) 1982-06-15
SU685149A3 (en) 1979-09-05
FI69070C (en) 1985-12-10
PT66282B (en) 1979-01-17
NO147950B (en) 1983-04-05
ZA771412B (en) 1978-11-29
US4154829A (en) 1979-05-15
DE2609645A1 (en) 1977-09-15
ES466598A1 (en) 1978-10-01
SU683616A3 (en) 1979-08-30
MY8500079A (en) 1985-12-31
ES466605A1 (en) 1978-10-01
US4271158A (en) 1981-06-02
SU698530A3 (en) 1979-11-15
IL51627A (en) 1980-10-26
MX4878E (en) 1982-11-26
SU676163A3 (en) 1979-07-25
CH630361A5 (en) 1982-06-15
FR2343731B1 (en) 1982-02-26
IL51627A0 (en) 1977-05-31
JPS52108970A (en) 1977-09-12
SE435059B (en) 1984-09-03
PL111240B1 (en) 1980-08-30
NO147950C (en) 1983-07-13
BE852223A (en) 1977-09-08
ES466603A1 (en) 1978-10-01
PH16110A (en) 1983-06-30
CH630362A5 (en) 1982-06-15
FR2372810A1 (en) 1978-06-30
ES466606A1 (en) 1978-10-01
CA1086317A (en) 1980-09-23
FI69070B (en) 1985-08-30
FI770586A (en) 1977-09-10
ES466602A1 (en) 1978-10-01
BG28051A4 (en) 1980-02-25
CS220320B2 (en) 1983-03-25
AT360542B (en) 1981-01-12
RO70569A (en) 1981-11-24
BG28052A4 (en) 1980-02-25
FR2372810B1 (en) 1982-11-26
NO770804L (en) 1977-09-12
BG27743A3 (en) 1979-12-12
HU177953B (en) 1982-02-28
ES466604A1 (en) 1978-10-01
GB1571231A (en) 1980-07-09
CS209435B2 (en) 1981-12-31
ES466599A1 (en) 1978-10-01
RO79706A (en) 1982-08-17
NL7702403A (en) 1977-09-13
ES466601A1 (en) 1978-10-01
GR64553B (en) 1980-04-14
AU2300977A (en) 1978-09-14
ATA122377A (en) 1980-06-15
PH16149A (en) 1983-07-12
JPS6172A (en) 1986-01-06
BG28053A4 (en) 1980-02-25
HK12884A (en) 1984-02-24
CH630364A5 (en) 1982-06-15
DK102177A (en) 1977-09-10
ES466600A1 (en) 1978-10-01
CH630363A5 (en) 1982-06-15
DD130037A5 (en) 1978-03-01
PH17635A (en) 1984-10-18

Similar Documents

Publication Publication Date Title
PL201586A1 (en) METHOD OF MAKING NEW SPIRO-HYDANTION COMPOUNDS
PL196505A1 (en) METHOD OF MAKING NEW AMINO-ALKYLETERCYCLIC COMPOUNDS
PL201286A1 (en) METHOD OF MAKING NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE-AMINOPROPANE
PL200289A1 (en) METHOD OF MAKING 3-CHLOROCEPHEMIC COMPOUNDS
PL215007A1 (en) METHOD OF MAKING GAMMA-PYRONY
PL201837A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL199298A1 (en) METHOD OF MAKING 2-BROMO-6-FLUORO-N-2-IMIDAZOLIDINYLIDENE-BENZAMINE
PL200251A1 (en) METHOD OF MAKING NEW SUBSTITUTED 2-PHENYLAMINEIMIDAZOLINE- / 2 /
PL200534A1 (en) METHOD OF MAKING NEW OXADESTIACHALOSPORINES
PL200583A1 (en) METHOD OF MAKING NEW BENZOPIRANE DERIVATIVES
PL199633A1 (en) METHOD OF MAKING 5-M-TOLYLOXYURACYL
PL200605A1 (en) METHOD OF MAKING NEW METHIONINOENKEPHALIN DERIVATIVES
PL202091A1 (en) METHOD OF MAKING GAMMA-PYRONOW
PL201133A1 (en) METHOD OF MAKING NEW PIRYDOBENZODWUAZEPINONOV
PL201839A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL202660A1 (en) METHOD OF MAKING NEW DERIVATIVES OF SPIROOXAZOLIDYNODION
PL195267A1 (en) METHOD OF MAKING (2-KETOPYROLIDININE) -ALCANOCARBONAMIDE
PL201161A1 (en) METHOD OF MAKING NEW DERIVATIVES OF 9-CHLOROPREDISOLONE
PL196061A1 (en) METHOD OF MAKING NEW DERIVATIVES OF INDOLYSIN
PL197311A1 (en) METHOD OF MAKING NEW KETOTIA COMPOUNDS
PL201883A1 (en) METHOD OF MAKING NEW TRANS-5A-ARYL-CHABENZAZEPINE DERIVATIVES
PL202697A1 (en) METHOD OF MAKING 2-BROMO-ALPHA-ERGOCRYPTIN
PL196543A1 (en) METHOD OF MAKING NEW DERIVATIVES OF ASIRIDINE
PL199191A1 (en) METHOD OF MAKING NEW GLYCINAMIDES
PL198294A1 (en) METHOD OF MAKING NEW TIAZOLE COMPOUNDS